{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:55:14Z","timestamp":1790661314285,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11882-019-0860-8","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T06:03:47Z","timestamp":1553580227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Th9 Cells in Allergic Disease"],"prefix":"10.1007","volume":"19","author":[{"given":"Pornpimon","family":"Angkasekwinai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"issue":"12","key":"860_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ni.1659","volume":"9","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008;9(12):1341\u20136. \n                      https:\/\/doi.org\/10.1038\/ni.1659\n                      \n                    .","journal-title":"Nat Immunol"},{"issue":"12","key":"860_CR2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ni.1677","volume":"9","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, et al. IL-4 inhibits TGF-beta-induced Foxp3(+) T cells and, together with TGF-beta, generates IL-9(+) IL-10(+) Foxp3(\u2212) effector T cells. Nat Immunol. 2008;9(12):1347\u201355. \n                      https:\/\/doi.org\/10.1038\/ni.1677\n                      \n                    .","journal-title":"Nat Immunol"},{"issue":"11","key":"860_CR3","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1172\/JCI69489","volume":"123","author":"R Jabeen","year":"2013","unstructured":"Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A, et al. Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest. 2013;123(11):4641\u201353. \n                      https:\/\/doi.org\/10.1172\/JCI69489\n                      \n                    .","journal-title":"J Clin Invest"},{"issue":"31","key":"860_CR4","doi-asserted-by":"publisher","first-page":"eaat5943","DOI":"10.1126\/sciimmunol.aat5943","volume":"4","author":"Claire Micoss\u00e9","year":"2019","unstructured":"\u2022\u2022 Micosse C, von Meyenn L, Steck O, Kipfer E, Adam C, Simillion C, et al. Human \"TH9\" cells are a subpopulation of PPAR-gamma(+) TH2 cells. Sci Immunol. 2019;4(31). \n                      https:\/\/doi.org\/10.1126\/sciimmunol.aat5943\n                      \n                     COMMENT: Study showing that Th9 subset transiently induced during skin inflammation is a subpopulation of Th2 lineage.","journal-title":"Science Immunology"},{"issue":"1","key":"860_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00281-016-0607-8","volume":"39","author":"RA Clark","year":"2017","unstructured":"Clark RA, Schlapbach C. TH9 cells in skin disorders. Semin Immunopathol. 2017;39(1):47\u201354. \n                      https:\/\/doi.org\/10.1007\/s00281-016-0607-8\n                      \n                    .","journal-title":"Semin Immunopathol"},{"issue":"4","key":"860_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.immuni.2013.07.020","volume":"39","author":"P Licona-Limon","year":"2013","unstructured":"Licona-Limon P, Henao-Mejia J, Temann AU, Gagliani N, Licona-Limon I, Ishigame H, et al. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity. 2013;39(4):744\u201357. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2013.07.020\n                      \n                    .","journal-title":"Immunity."},{"issue":"10","key":"860_CR7","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1128\/IAI.00646-13","volume":"81","author":"P Angkasekwinai","year":"2013","unstructured":"Angkasekwinai P, Srimanote P, Wang YH, Pootong A, Sakolvaree Y, Pattanapanyasat K, et al. Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response. Infect Immun. 2013;81(10):3731\u201341. \n                      https:\/\/doi.org\/10.1128\/IAI.00646-13\n                      \n                    .","journal-title":"Infect Immun"},{"issue":"4","key":"860_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jaci.2011.12.965","volume":"129","author":"CP Jones","year":"2012","unstructured":"Jones CP, Gregory LG, Causton B, Campbell GA, Lloyd CM. Activin a and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol. 2012;129(4):1000\u201310 e3. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2011.12.965\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"860_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ni.1846","volume":"11","author":"P Angkasekwinai","year":"2010","unstructured":"Angkasekwinai P, Chang SH, Thapa M, Watarai H, Dong C. Regulation of IL-9 expression by IL-25 signaling. Nat Immunol. 2010;11(3):250\u20136. \n                      https:\/\/doi.org\/10.1038\/ni.1846\n                      \n                    .","journal-title":"Nat Immunol"},{"issue":"6","key":"860_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ni.1867","volume":"11","author":"HC Chang","year":"2010","unstructured":"Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol. 2010;11(6):527\u201334. \n                      https:\/\/doi.org\/10.1038\/ni.1867\n                      \n                    .","journal-title":"Nat Immunol"},{"issue":"1","key":"860_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00281-016-0599-4","volume":"39","author":"TR Vargas","year":"2017","unstructured":"Vargas TR, Humblin E, Vegran F, Ghiringhelli F, Apetoh L. T(H)9 cells in anti-tumor immunity. Semin Immunopathol. 2017;39(1):39\u201346. \n                      https:\/\/doi.org\/10.1007\/s00281-016-0599-4\n                      \n                    .","journal-title":"Semin Immunopathol"},{"issue":"1\u20132","key":"860_CR12","doi-asserted-by":"publisher","DOI":"10.4161\/21688370.2014.983777","volume":"3","author":"K Gerlach","year":"2015","unstructured":"Gerlach K, McKenzie AN, Neurath MF, Weigmann B. IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis. Tissue Barriers. 2015;3(1\u20132):e983777. \n                      https:\/\/doi.org\/10.4161\/21688370.2014.983777\n                      \n                    .","journal-title":"Tissue Barriers"},{"issue":"3","key":"860_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jaci.2003.11.025","volume":"113","author":"S Romagnani","year":"2004","unstructured":"Romagnani S. Immunologic influences on allergy and theT(H)1\/T(H)2 balance. J Allergy Clin Immunol. 2004;113(3):395\u2013400. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2003.11.025\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"7280","key":"860_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540\u20134. \n                      https:\/\/doi.org\/10.1038\/nature08636\n                      \n                    .","journal-title":"Nature."},{"issue":"25","key":"860_CR15","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.1003988107","volume":"107","author":"AE Price","year":"2010","unstructured":"Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A. 2010;107(25):11489\u201394. \n                      https:\/\/doi.org\/10.1073\/pnas.1003988107\n                      \n                    .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7293","key":"860_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","volume":"464","author":"DR Neill","year":"2010","unstructured":"Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464(7293):1367\u201370. \n                      https:\/\/doi.org\/10.1038\/nature08900\n                      \n                    .","journal-title":"Nature."},{"issue":"3","key":"860_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","volume":"40","author":"TY Halim","year":"2014","unstructured":"Halim TY, Steer CA, Matha L, Gold MJ, Martinez-Gonzalez I, McNagny KM, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 2014;40(3):425\u201335. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2014.01.011\n                      \n                    .","journal-title":"Immunity."},{"issue":"8","key":"860_CR18","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.4049\/jimmunol.1400951","volume":"194","author":"B Liu","year":"2015","unstructured":"Liu B, Lee JB, Chen CY, Hershey GK, Wang YH. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol. 2015;194(8):3583\u201393. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1400951\n                      \n                    .","journal-title":"J Immunol"},{"issue":"301","key":"860_CR19","doi-asserted-by":"publisher","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","volume":"7","author":"DF Choy","year":"2015","unstructured":"Choy DF, Hart KM, Borthwick LA, Shikotra A, Nagarkar DR, Siddiqui S, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med. 2015;7(301):301ra129. \n                      https:\/\/doi.org\/10.1126\/scitranslmed.aab3142\n                      \n                    .","journal-title":"Sci Transl Med"},{"issue":"2","key":"860_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jaci.2015.01.021","volume":"136","author":"S Sehra","year":"2015","unstructured":"Sehra S, Yao W, Nguyen ET, Glosson-Byers NL, Akhtar N, Zhou B, et al. TH9 cells are required for tissue mast cell accumulation during allergic inflammation. J Allergy Clin Immunol. 2015;136(2):433\u201340 e1. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2015.01.021\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"860_CR21","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1073\/pnas.0911756107","volume":"107","author":"BS Kim","year":"2010","unstructured":"Kim BS, Kim IK, Park YJ, Kim YS, Kim YJ, Chang WS, et al. Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma. Proc Natl Acad Sci U S A. 2010;107(19):8742\u20137. \n                      https:\/\/doi.org\/10.1073\/pnas.0911756107\n                      \n                    .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"860_CR22","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.4049\/jimmunol.1200808","volume":"189","author":"G Murugaiyan","year":"2012","unstructured":"Murugaiyan G, Beynon V, Da Cunha AP, Joller N, Weiner HL. IFN-gamma limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. J Immunol. 2012;189(11):5277\u201383. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1200808\n                      \n                    .","journal-title":"J Immunol"},{"issue":"5","key":"860_CR23","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.4049\/jimmunol.1300911","volume":"191","author":"R Anuradha","year":"2013","unstructured":"Anuradha R, George PJ, Hanna LE, Chandrasekaran V, Kumaran P, Nutman TB, et al. IL-4-, TGF-beta-, and IL-1-dependent expansion of parasite antigen-specific Th9 cells is associated with clinical pathology in human lymphatic Filariasis. J Immunol. 2013;191(5):2466\u201373. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1300911\n                      \n                    .","journal-title":"J Immunol"},{"issue":"9","key":"860_CR24","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1073\/pnas.1301138111","volume":"111","author":"W Liao","year":"2014","unstructured":"Liao W, Spolski R, Li P, Du N, West EE, Ren M, et al. Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. Proc Natl Acad Sci U S A. 2014;111(9):3508\u201313. \n                      https:\/\/doi.org\/10.1073\/pnas.1301138111\n                      \n                    .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"860_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.immuni.2013.01.007","volume":"38","author":"WG Yao","year":"2013","unstructured":"Yao WG, Zhang YL, Jabeen R, Nguyen ET, Wilkes DS, Tepper RS, et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity. 2013;38(2):360\u201372. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2013.01.007\n                      \n                    .","journal-title":"Immunity."},{"issue":"6","key":"860_CR26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/icb.2010.53","volume":"88","author":"MT Wong","year":"2010","unstructured":"Wong MT, Ye JJ, Alonso MN, Landrigan A, Cheung RK, Engleman E, et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol. 2010;88(6):624\u201331. \n                      https:\/\/doi.org\/10.1038\/icb.2010.53\n                      \n                    .","journal-title":"Immunol Cell Biol"},{"issue":"10","key":"860_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni.2390","volume":"13","author":"X Xiao","year":"2012","unstructured":"Xiao X, Balasubramanian S, Liu WT, Chu XF, Wang HB, Taparowsky EJ, et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol. 2012;13(10):981\u201390. \n                      https:\/\/doi.org\/10.1038\/ni.2390\n                      \n                    .","journal-title":"Nat Immunol"},{"issue":"4","key":"860_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jaci.2012.09.027","volume":"131","author":"J Kerzerho","year":"2013","unstructured":"Kerzerho J, Maazi H, Speak AO, Szely N, Lombardi V, Khoo B, et al. Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. J Allergy Clin Immunol. 2013;131(4):1048\u201357, 57 e1\u20132. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2012.09.027\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"860_CR29","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm.3922","volume":"21","author":"IK Kim","year":"2015","unstructured":"Kim IK, Kim BS, Koh CH, Seok JW, Park JS, Shin KS, et al. Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells. Nat Med. 2015;21(9):1010\u20137. \n                      https:\/\/doi.org\/10.1038\/nm.3922\n                      \n                    .","journal-title":"Nat Med"},{"key":"860_CR30","doi-asserted-by":"publisher","first-page":"8266","DOI":"10.1038\/ncomms9266","volume":"6","author":"X Xiao","year":"2015","unstructured":"Xiao X, Shi X, Fan Y, Zhang X, Wu M, Lan P, et al. GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun. 2015;6:8266. \n                      https:\/\/doi.org\/10.1038\/ncomms9266\n                      \n                    .","journal-title":"Nat Commun"},{"issue":"4","key":"860_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","volume":"36","author":"W Elyaman","year":"2012","unstructured":"Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, Zhu B, et al. Notch receptors and Smad3 signaling cooperate in the induction of Interleukin-9-producing T cells. Immunity. 2012;36(4):623\u201334. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2012.01.020\n                      \n                    .","journal-title":"Immunity."},{"issue":"8","key":"860_CR32","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.4049\/jimmunol.1401220","volume":"194","author":"AC Richard","year":"2015","unstructured":"Richard AC, Tan CY, Hawley ET, Gomez-Rodriguez J, Goswami R, Yang XP, et al. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells. J Immunol. 2015;194(8):3567\u201382. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1401220\n                      \n                    .","journal-title":"J Immunol"},{"issue":"3","key":"860_CR33","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4049\/jimmunol.1102840","volume":"188","author":"R Goswami","year":"2012","unstructured":"Goswami R, Jabeen R, Yagi R, Pham D, Zhu JF, Goenka S, et al. STAT6-dependent regulation of Th9 development. J Immunol. 2012;188(3):968\u201375. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1102840\n                      \n                    .","journal-title":"J Immunol"},{"issue":"2","key":"860_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","volume":"33","author":"V Staudt","year":"2010","unstructured":"Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity. 2010;33(2):192\u2013202. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2010.07.014\n                      \n                    .","journal-title":"Immunity."},{"issue":"26","key":"860_CR35","doi-asserted-by":"publisher","first-page":"15815","DOI":"10.1074\/jbc.271.26.15815","volume":"271","author":"YX Zhu","year":"1996","unstructured":"Zhu YX, Kang LY, Luo W, Li CC, Yang L, Yang YC. Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J Biol Chem. 1996;271(26):15815\u201322.","journal-title":"J Biol Chem"},{"issue":"19","key":"860_CR36","doi-asserted-by":"publisher","first-page":"15445","DOI":"10.1074\/jbc.M112.340356","volume":"287","author":"A Jash","year":"2012","unstructured":"Jash A, Sahoo A, Kim GC, Chae CS, Hwang JS, Kim JE, et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-kappaB (NF-kappaB)-mediated interleukin-9 (IL-9) transactivation. J Biol Chem. 2012;287(19):15445\u201357. \n                      https:\/\/doi.org\/10.1074\/jbc.M112.340356\n                      \n                    .","journal-title":"J Biol Chem"},{"issue":"5","key":"860_CR37","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.4049\/jimmunol.1301276","volume":"191","author":"T Tamiya","year":"2013","unstructured":"Tamiya T, Ichiyama K, Kotani H, Fukaya T, Sekiya T, Shichita T, et al. Smad2\/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J Immunol. 2013;191(5):2360\u201371. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1301276\n                      \n                    .","journal-title":"J Immunol"},{"issue":"1","key":"860_CR38","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s41467-017-01070-w","volume":"8","author":"E Humblin","year":"2017","unstructured":"Humblin E, Thibaudin M, Chalmin F, Derangere V, Limagne E, Richard C, et al. IRF8-dependent molecular complexes control the Th9 transcriptional program. Nat Commun. 2017;8(1):2085. \n                      https:\/\/doi.org\/10.1038\/s41467-017-01070-w\n                      \n                    .","journal-title":"Nat Commun"},{"issue":"1","key":"860_CR39","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41467-017-00674-6","volume":"8","author":"S Malik","year":"2017","unstructured":"Malik S, Sadhu S, Elesela S, Pandey RP, Chawla AS, Sharma D, et al. Transcription factor Foxo1 is essential for IL-9 induction in T helper cells. Nat Commun. 2017;8(1):815. \n                      https:\/\/doi.org\/10.1038\/s41467-017-00674-6\n                      \n                    .","journal-title":"Nat Commun"},{"issue":"2","key":"860_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1084\/jem.20170928","volume":"215","author":"X Xiao","year":"2018","unstructured":"\u2022\u2022 Xiao X, Fan Y, Li J, Zhang X, Lou X, Dou Y, et al. Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation. J Exp Med. 2018;215(2):559\u201374. \n                      https:\/\/doi.org\/10.1084\/jem.20170928\n                      \n                     COMMENT: Study identifying the elements for the epigenetic landscape regulating IL-9 expression by Th9 cells that could be another target for allergic airway inflammation.","journal-title":"J Exp Med"},{"issue":"1","key":"860_CR41","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1038\/s41467-018-07202-0","volume":"9","author":"B Koh","year":"2018","unstructured":"\u2022\u2022 Koh B, Abdul Qayum A, Srivastava R, Fu Y, Ulrich BJ, Janga SC, et al. A conserved enhancer regulates Il9 expression in multiple lineages. Nat Commun. 2018;9(1):4803. \n                      https:\/\/doi.org\/10.1038\/s41467-018-07202-0\n                      \n                     COMMENT: Study identifying a conserved IL-9 regulatory element, CNS-25 as enhancer for IL-9 expression in multiple cell types, including Th9 cells.","journal-title":"Nat Commun"},{"issue":"4","key":"860_CR42","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.immuni.2015.08.020","volume":"43","author":"CY Chen","year":"2015","unstructured":"Chen CY, Lee JB, Liu B, Ohta S, Wang PY, Kartashov AV, et al. Induction of Interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy. Immunity. 2015;43(4):788\u2013802. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2015.08.020\n                      \n                    .","journal-title":"Immunity."},{"issue":"13","key":"860_CR43","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1084\/jem.20130071","volume":"210","author":"JE Turner","year":"2013","unstructured":"Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med. 2013;210(13):2951\u201365. \n                      https:\/\/doi.org\/10.1084\/jem.20130071\n                      \n                    .","journal-title":"J Exp Med"},{"issue":"8","key":"860_CR44","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.4373","volume":"23","author":"S Rauber","year":"2017","unstructured":"Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat Med. 2017;23(8):938\u201344. \n                      https:\/\/doi.org\/10.1038\/nm.4373\n                      \n                    .","journal-title":"Nat Med"},{"issue":"3","key":"860_CR45","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/eji.201242825","volume":"43","author":"A Visekruna","year":"2013","unstructured":"Visekruna A, Ritter J, Scholz T, Campos L, Guralnik A, Poncette L, et al. Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation. Eur J Immunol. 2013;43(3):606\u201318. \n                      https:\/\/doi.org\/10.1002\/eji.201242825\n                      \n                    .","journal-title":"Eur J Immunol"},{"issue":"8","key":"860_CR46","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20090246","volume":"206","author":"EC Nowak","year":"2009","unstructured":"Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009;206(8):1653\u201360. \n                      https:\/\/doi.org\/10.1084\/jem.20090246\n                      \n                    .","journal-title":"J Exp Med"},{"issue":"31","key":"860_CR47","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0812530106","volume":"106","author":"W Elyaman","year":"2009","unstructured":"Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A. 2009;106(31):12885\u201390. \n                      https:\/\/doi.org\/10.1073\/pnas.0812530106\n                      \n                    .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4 Pt 1","key":"860_CR48","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1164\/ajrccm.153.4.8616554","volume":"153","author":"IJ Doull","year":"1996","unstructured":"Doull IJ, Lawrence S, Watson M, Begishvili T, Beasley RW, Lampe F, et al. Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 1996;153(4 Pt 1):1280\u20134. \n                      https:\/\/doi.org\/10.1164\/ajrccm.153.4.8616554\n                      \n                    .","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Pt 1","key":"860_CR49","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0091-6749(97)80018-8","volume":"99","author":"M Ulbrecht","year":"1997","unstructured":"Ulbrecht M, Eisenhut T, Bonisch J, Kruse R, Wjst M, Heinrich J, et al. High serum IgE concentrations: association with HLA-DR and markers on chromosome 5q31 and chromosome 11q13. J Allergy Clin Immunol. 1997;99(6 Pt 1):828\u201336.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"860_CR50","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S","volume":"29","author":"Q Dong","year":"1999","unstructured":"Dong Q, Louahed J, Vink A, Sullivan CD, Messler CJ, Zhou Y, et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol. 1999;29(7):2130\u20139. \n                      https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199907)29:07<2130::AID-IMMU2130>3.0.CO;2-S\n                      \n                    .","journal-title":"Eur J Immunol"},{"issue":"10","key":"860_CR51","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1172\/JCI6097","volume":"104","author":"M Longphre","year":"1999","unstructured":"Longphre M, Li D, Gallup M, Drori E, Ordonez CL, Redman T, et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest. 1999;104(10):1375\u201382. \n                      https:\/\/doi.org\/10.1172\/JCI6097\n                      \n                    .","journal-title":"J Clin Invest"},{"issue":"1","key":"860_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI13696","volume":"109","author":"UA Temann","year":"2002","unstructured":"Temann UA, Ray P, Flavell RA. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest. 2002;109(1):29\u201339. \n                      https:\/\/doi.org\/10.1172\/JCI13696\n                      \n                    .","journal-title":"J Clin Invest"},{"issue":"4","key":"860_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1074-7613(00)00056-X","volume":"13","author":"JM Townsend","year":"2000","unstructured":"Townsend JM, Fallon GP, Matthews JD, Smith P, Jolin EH, McKenzie NA. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity. 2000;13(4):573\u201383.","journal-title":"Immunity."},{"issue":"5","key":"860_CR54","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1165\/ajrcmb.25.5.4533","volume":"25","author":"TT Kung","year":"2001","unstructured":"Kung TT, Luo B, Crawley Y, Garlisi CG, Devito K, Minnicozzi M, et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol. 2001;25(5):600\u20135. \n                      https:\/\/doi.org\/10.1165\/ajrcmb.25.5.4533\n                      \n                    .","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"860_CR55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1164\/rccm.2105079","volume":"166","author":"G Cheng","year":"2002","unstructured":"Cheng G, Arima M, Honda K, Hirata H, Eda F, Yoshida N, et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med. 2002;166(3):409\u201316. \n                      https:\/\/doi.org\/10.1164\/rccm.2105079\n                      \n                    .","journal-title":"Am J Respir Crit Care Med"},{"key":"860_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4939-6877-0_15","volume":"1585","author":"P Angkasekwinai","year":"2017","unstructured":"Angkasekwinai P. Allergic inflammation and atopic disease: role of Th9 cells. Methods Mol Biol. 2017;1585:189\u201399. \n                      https:\/\/doi.org\/10.1007\/978-1-4939-6877-0_15\n                      \n                    .","journal-title":"Methods Mol Biol"},{"issue":"11","key":"860_CR57","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni.2133","volume":"12","author":"C Wilhelm","year":"2011","unstructured":"Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol. 2011;12(11):1071\u20137. \n                      https:\/\/doi.org\/10.1038\/ni.2133\n                      \n                    .","journal-title":"Nat Immunol"},{"key":"860_CR58","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1038\/ncomms14017","volume":"8","author":"S Moretti","year":"2017","unstructured":"\u2022\u2022 Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, et al. A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. Nat Commun. 2017;8:14017. \n                      https:\/\/doi.org\/10.1038\/ncomms14017\n                      \n                     COMMENT: Study indicating the collaborative network of Th9, ILC2 and mast cells in amplifying lung inflammation.","journal-title":"Nat Commun"},{"issue":"1 Pt 1","key":"860_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0091-6749(00)90185-4","volume":"105","author":"A Shimbara","year":"2000","unstructured":"Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol. 2000;105(1 Pt 1):108\u201315.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"860_CR60","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1067\/mai.2003.1485","volume":"111","author":"VJ Erpenbeck","year":"2003","unstructured":"Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol. 2003;111(6):1319\u201327.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"860_CR61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaci.2005.03.011","volume":"116","author":"KT Nouri-Aria","year":"2005","unstructured":"Nouri-Aria KT, Pilette C, Jacobson MR, Watanabe H, Durham SR. IL-9 and c-kit(+) mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol. 2005;116(1):73\u20139. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2005.03.011\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"860_CR62","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2222.2006.02422.x","volume":"36","author":"S Devos","year":"2006","unstructured":"Devos S, Cormont F, Vrtala S, Hooghe-Peters E, Pirson F, Van Snick J. Allergen-induced interleukin-9 production in vitro: correlation with atopy in human adults and comparison with interleukin-5 and interleukin-13. Clin Exp Allergy. 2006;36(2):174\u201382. \n                      https:\/\/doi.org\/10.1111\/j.1365-2222.2006.02422.x\n                      \n                    .","journal-title":"Clin Exp Allergy"},{"key":"860_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000101410","volume":"143","author":"M Umezu-Goto","year":"2007","unstructured":"Umezu-Goto M, Kajiyama Y, Kobayashi N, Kaminuma O, Suko M, Mori A. IL-9 production by peripheral blood mononuclear cells of atopic asthmatics. Int Arch Allergy Immunol. 2007;143:76\u20139. \n                      https:\/\/doi.org\/10.1159\/000101410\n                      \n                    .","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"860_CR64","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jaci.2011.06.019","volume":"128","author":"WG Yao","year":"2011","unstructured":"Yao WG, Tepper RS, Kaplan MH. Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol. 2011;128(6):1357\u201360. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2011.06.019\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"860_CR65","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.anai.2015.01.013","volume":"114","author":"T Iinuma","year":"2015","unstructured":"Iinuma T, Okamoto Y, Yamamoto H, Inamine-Sasaki A, Ohki Y, Sakurai T, et al. Interleukin-25 and mucosal T cells in noneosinophilic and eosinophilic chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2015;114(4):289\u201398. \n                      https:\/\/doi.org\/10.1016\/j.anai.2015.01.013\n                      \n                    .","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"860_CR66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medici.2015.01.001","volume":"51","author":"D Hoppenot","year":"2015","unstructured":"Hoppenot D, Malakauskas K, Lavinskiene S, Bajoriuniene I, Kalinauskaite V, Sakalauskas R. Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients. Medicina-Lithuania. 2015;51(1):10\u20137. \n                      https:\/\/doi.org\/10.1016\/j.medici.2015.01.001\n                      \n                    .","journal-title":"Medicina-Lithuania."},{"issue":"1","key":"860_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12865-017-0220-1","volume":"18","author":"L Jia","year":"2017","unstructured":"Jia L, Wang Y, Li J, Li S, Zhang Y, Shen J, et al. Detection of IL-9 producing T cells in the PBMCs of allergic asthmatic patients. BMC Immunol. 2017;18(1):38. \n                      https:\/\/doi.org\/10.1186\/s12865-017-0220-1\n                      \n                    .","journal-title":"BMC Immunol"},{"issue":"14","key":"860_CR68","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483\u201394. \n                      https:\/\/doi.org\/10.1056\/NEJMra074081\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"2","key":"860_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.anai.2017.11.023","volume":"120","author":"AJ Lowe","year":"2018","unstructured":"Lowe AJ, Leung DYM, Tang MLK, Su JC, Allen KJ. The skin as a target for prevention of the atopic march. Ann Allergy Asthma Immunol. 2018;120(2):145\u201351. \n                      https:\/\/doi.org\/10.1016\/j.anai.2017.11.023\n                      \n                    .","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"860_CR70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","volume":"371","author":"LA Beck","year":"2014","unstructured":"Beck LA, Thaci D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130\u20139. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1314768\n                      \n                    .","journal-title":"N Engl J Med"},{"issue":"10013","key":"860_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(15)00388-8","volume":"387","author":"D Thaci","year":"2016","unstructured":"\u2022\u2022 Thaci D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K, et al. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet. 2016;387(10013):40\u201352. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(15)00388-8\n                      \n                     COMMENT: Clinical trial study indicating the effect of targeting Th2 cytokine IL-4 and IL-13 in atopic dermatitis.","journal-title":"Lancet"},{"issue":"2","key":"860_CR72","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","volume":"138","author":"T Werfel","year":"2016","unstructured":"Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):336\u201349. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2016.06.010\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"3 Pt 1","key":"860_CR73","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/jid.2011.382","volume":"132","author":"JY Lin","year":"2012","unstructured":"Lin JY, Chen JS, Hsu CJ, Miaw SC, Liu CY, Lee SJ, et al. Epicutaneous sensitization with protein antigen induces Th9 cells. J Invest Dermatol. 2012;132(3 Pt 1):739\u201341. \n                      https:\/\/doi.org\/10.1038\/jid.2011.382\n                      \n                    .","journal-title":"J Invest Dermatol."},{"issue":"1","key":"860_CR74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jdermsci.2011.01.007","volume":"62","author":"JH Namkung","year":"2011","unstructured":"Namkung JH, Lee JE, Kim E, Park GT, Yang HS, Jang HY, et al. An association between IL-9 and IL-9 receptor gene polymorphisms and atopic dermatitis in a Korean population. J Dermatol Sci. 2011;62(1):16\u201321. \n                      https:\/\/doi.org\/10.1016\/j.jdermsci.2011.01.007\n                      \n                    .","journal-title":"J Dermatol Sci"},{"issue":"3","key":"860_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033271","volume":"7","author":"N Sismanopoulos","year":"2012","unstructured":"Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Vasiadi M, Therianou A, et al. IL-9 induces VEGF secretion from human mast cells and IL-9\/IL-9 receptor genes are overexpressed in atopic dermatitis. PLoS One. 2012;7(3):e33271. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0033271\n                      \n                    .","journal-title":"PLoS One"},{"issue":"2","key":"860_CR76","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1525-1470.2012.01766.x","volume":"30","author":"G Ciprandi","year":"2013","unstructured":"Ciprandi G, De Amici M, Giunta V, Marseglia A, Marseglia G. Serum Interleukin-9 levels are associated with clinical severity in children with atopic dermatitis. Pediatr Dermatol. 2013;30(2):222\u20135. \n                      https:\/\/doi.org\/10.1111\/j.1525-1470.2012.01766.x\n                      \n                    .","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"860_CR77","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ijd.13579","volume":"56","author":"AM Hamza","year":"2017","unstructured":"Hamza AM, Omar SS, Abo El-Wafa RA, Elatrash MJ. Expression levels of transcription factor PU.1 and interleukin-9 in atopic dermatitis and their relation to disease severity and eruption types. Int J Dermatol. 2017;56(5):534\u20139. \n                      https:\/\/doi.org\/10.1111\/ijd.13579\n                      \n                    .","journal-title":"Int J Dermatol"},{"issue":"6","key":"860_CR78","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","volume":"138","author":"H Esaki","year":"2016","unstructured":"Esaki H, Brunner PM, Renert-Yuval Y, Czarnowicki T, Huynh T, Tran G, et al. Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin. J Allergy Clin Immunol. 2016;138(6):1639\u201351. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2016.07.013\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"219","key":"860_CR79","doi-asserted-by":"publisher","first-page":"219ra8","DOI":"10.1126\/scitranslmed.3007828","volume":"6","author":"C Schlapbach","year":"2014","unstructured":"Schlapbach C, Gehad A, Yang C, Watanabe R, Guenova E, Teague JE, et al. Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity. Sci Transl Med. 2014;6(219):219ra8. \n                      https:\/\/doi.org\/10.1126\/scitranslmed.3007828\n                      \n                    .","journal-title":"Sci Transl Med"},{"issue":"1","key":"860_CR80","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cei.12198","volume":"175","author":"L Ma","year":"2014","unstructured":"Ma L, Xue HB, Guan XH, Shu CM, Zhang JH, Yu J. Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin Exp Immunol. 2014;175(1):25\u201331. \n                      https:\/\/doi.org\/10.1111\/cei.12198\n                      \n                    .","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"860_CR81","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/jid.2009.187","volume":"130","author":"EM Coulter","year":"2010","unstructured":"Coulter EM, Jenkinson C, Farrell J, Lavergne SN, Pease C, White A, et al. Measurement of CD4+ and CD8+ T-lymphocyte cytokine secretion and gene expression changes in p-phenylenediamine allergic patients and tolerant individuals. J Invest Dermatol. 2010;130(1):161\u201374. \n                      https:\/\/doi.org\/10.1038\/jid.2009.187\n                      \n                    .","journal-title":"J Invest Dermatol"},{"issue":"6","key":"860_CR82","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/cod.13123","volume":"79","author":"M Baeck","year":"2018","unstructured":"Baeck M, Herman A, de Montjoye L, Hendrickx E, Cheou P, Cochez PM, et al. Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamine. Contact Dermatitis. 2018;79(6):346\u201355. \n                      https:\/\/doi.org\/10.1111\/cod.13123\n                      \n                    .","journal-title":"Contact Dermatitis"},{"issue":"7","key":"860_CR83","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/jid.2014.61","volume":"134","author":"J Liu","year":"2014","unstructured":"Liu J, Harberts E, Tammaro A, Girardi N, Filler RB, Fishelevich R, et al. IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol. 2014;134(7):1903\u201311. \n                      https:\/\/doi.org\/10.1038\/jid.2014.61\n                      \n                    .","journal-title":"J Invest Dermatol."},{"issue":"1","key":"860_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4049\/jimmunol.1001183","volume":"186","author":"K Eller","year":"2011","unstructured":"Eller K, Wolf D, Huber JM, Metz M, Mayer G, McKenzie AN, et al. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol. 2011;186(1):83\u201391. \n                      https:\/\/doi.org\/10.4049\/jimmunol.1001183\n                      \n                    .","journal-title":"J Immunol"},{"issue":"6","key":"860_CR85","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1053\/j.gastro.2015.02.006","volume":"148","author":"R Valenta","year":"2015","unstructured":"Valenta R, Hochwallner H, Linhart B, Pahr S. Food allergies: the basics. Gastroenterology. 2015;148(6):1120\u201331 e4. \n                      https:\/\/doi.org\/10.1053\/j.gastro.2015.02.006\n                      \n                    .","journal-title":"Gastroenterology."},{"issue":"4","key":"860_CR86","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1084\/jem.20071046","volume":"205","author":"EE Forbes","year":"2008","unstructured":"Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C, et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med. 2008;205(4):897\u2013913. \n                      https:\/\/doi.org\/10.1084\/jem.20071046\n                      \n                    .","journal-title":"J Exp Med"},{"issue":"2","key":"860_CR87","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jaci.2009.09.054","volume":"125","author":"H Osterfeld","year":"2010","unstructured":"Osterfeld H, Ahrens R, Strait R, Finkelman FD, Renauld JC, Hogan SP. Differential roles for the IL-9\/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. J Allergy Clin Immunol. 2010;125(2):469\u201376 e2. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2009.09.054\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"860_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2249.2011.04394.x","volume":"165","author":"SH He","year":"2011","unstructured":"He SH, Liu ZQ, Chen X, Song CH, Zhou LF, Ma WJ, et al. IL-9(+) IL-10(+) T cells link immediate allergic response to late phase reaction. Clin Exp Immunol. 2011;165(1):29\u201337. \n                      https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04394.x\n                      \n                    .","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"860_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045377","volume":"7","author":"J Xie","year":"2012","unstructured":"Xie J, Lotoski LC, Chooniedass R, Su RC, Simons FE, Liem J, et al. Elevated antigen-driven IL-9 responses are prominent in peanut allergic humans. PLoS One. 2012;7(10):e45377. \n                      https:\/\/doi.org\/10.1371\/journal.pone.0045377\n                      \n                    .","journal-title":"PLoS One"},{"issue":"6","key":"860_CR90","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jaci.2014.06.032","volume":"134","author":"HA Brough","year":"2014","unstructured":"Brough HA, Cousins DJ, Munteanu A, Wong YF, Sudra A, Makinson K, et al. IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. J Allergy Clin Immunol. 2014;134(6):1329\u201338 e10. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2014.06.032\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"860_CR91","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00281-016-0605-x","volume":"39","author":"D Shik","year":"2017","unstructured":"Shik D, Tomar S, Lee JB, Chen CY, Smith A, Wang YH. IL-9-producing cells in the development of IgE-mediated food allergy. Semin Immunopathol. 2017;39(1):69\u201377. \n                      https:\/\/doi.org\/10.1007\/s00281-016-0605-x\n                      \n                    .","journal-title":"Semin Immunopathol"},{"issue":"2","key":"860_CR92","first-page":"233","volume":"12","author":"SA Antoniu","year":"2010","unstructured":"Antoniu SA. MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma. Curr Opin Mol Ther. 2010;12(2):233\u20139.","journal-title":"Curr Opin Mol Ther"},{"key":"860_CR93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2466-11-14","volume":"11","author":"JM Parker","year":"2011","unstructured":"Parker JM, Oh CK, LaForce C, Miller SD, Pearlman DS, Le C, et al. Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulm Med. 2011;11:14. \n                      https:\/\/doi.org\/10.1186\/1471-2466-11-14\n                      \n                    .","journal-title":"BMC Pulm Med"},{"key":"860_CR94","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1465-9921-14-93","volume":"14","author":"CK Oh","year":"2013","unstructured":"Oh CK, Leigh R, McLaurin KK, Kim K, Hultquist M, Molfino NA. A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma. Respir Res. 2013;14:93. \n                      https:\/\/doi.org\/10.1186\/1465-9921-14-93\n                      \n                    .","journal-title":"Respir Res"},{"issue":"5","key":"860_CR95","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","volume":"137","author":"A Muraro","year":"2016","unstructured":"Muraro A, Lemanske RF Jr, Hellings PW, Akdis CA, Bieber T, Casale TB, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European academy of allergy and clinical immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347\u201358. \n                      https:\/\/doi.org\/10.1016\/j.jaci.2016.03.010\n                      \n                    .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"860_CR96","doi-asserted-by":"publisher","first-page":"106\u201320 e10","DOI":"10.1016\/j.immuni.2018.12.014","volume":"50","author":"DM Schwartz","year":"2019","unstructured":"\u2022\u2022 Schwartz DM, Farley TK, Richoz N, Yao C, Shih HY, Petermann F, et al. Retinoic Acid Receptor Alpha Represses a Th9 Transcriptional and Epigenomic Program to Reduce Allergic Pathology. Immunity. 2019;50(1):106\u201320 e10. \n                      https:\/\/doi.org\/10.1016\/j.immuni.2018.12.014\n                      \n                     COMMENT: Study indicating the effect of retinoic acid on transcriptome of Th9 cells and repressing Th9 epigenome can control allergic lung pathology.","journal-title":"Immunity"},{"issue":"1","key":"860_CR97","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1056\/NEJMcibr1803610","volume":"379","author":"CM Lloyd","year":"2018","unstructured":"Lloyd CM, Harker JA. Epigenetic control of Interleukin-9 in asthma. N Engl J Med. 2018;379(1):87\u20139. \n                      https:\/\/doi.org\/10.1056\/NEJMcibr1803610\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"860_CR98","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","volume":"199","author":"MC McGregor","year":"2018","unstructured":"McGregor MC, Krings JG, Nair P, Castro M. Role of biologics in asthma. Am J Respir Crit Care Med. 2018;199:433\u201345. \n                      https:\/\/doi.org\/10.1164\/rccm.201810-1944CI\n                      \n                    .","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-019-0860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-019-0860-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-019-0860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:31:47Z","timestamp":1585096307000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-019-0860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s11882-019-0860-8","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"26 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicting financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"29"}}